Revelation Biosciences Inc - Warrant — Financial Statistics (NASDAQ:REVBW)

Financials

Key stats

Total common shares outstanding 45.1374.82783.318 504.8775.44 K3.72 M —

Valuation ratios

Enterprise value —————— — Price to earnings ratio ——-0-0-0-0 -0 Price to sales ratio —————— — Price to cash flow ratio ——-0-0-0-0 -0 Price to book ratio ——0000 0 Enterprise value to EBITDA ratio —————— —

Profitability ratios

Return on assets % 0-0.041.960.01-2.27-0.77 -1.33 Return on equity % 0.030.279.820.02-3.2-1.01 -1.81 Return on invested capital % -0.79—-159.57-1 131.77-2 008.72-8 508.34 -69.73 K Gross margin % —————14.31 K — Operating margin % —————80.94 K — EBITDA margin % —————95.01 K — Net margin % —————79.54 K —

Liquidity ratios

Quick ratio —————— — Current ratio 19.280.021.222.183.435.41 19.35 Inventory turnover —————— — Asset turnover —————-0 —

Solvency ratios

Debt to assets ratio —————— — Debt to equity ratio —————— — Long term debt to total assets ratio —————— — Long term debt to total equity ratio —————— —

Per share metrics

Operating cash flow per share —-80.4 K-119.89 K-6 118.62-1 281.88-13.32 -49.66 EBIT per share —————-17.2 — EBITDA per share —————-17.15 — Total debt per share —————— — Cash per share —8 701.1456.63 K10.08 K454.7817.24 108.07 Net current asset value per share —9 236.7357.84 K10.2 K459.3817.42 112.06 Tangible book value per share —-866.73 K11.75 K5 542.31328.8414.27 85.68 Working capital per share —-598.61 K10.28 K5 527.73325.4914.2 84.76 Book value per share —-866.73 K11.75 K5 542.31328.8414.27 85.68